Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 25539-1:2017 – Cardiovascular Implants – Endovascular Prostheses
Requirements for Stent-Grafts and Endovascular Aneurysm Repair Devices
Introduction to ISO 25539-1:2017
ISO 25539-1:2017 specifies requirements for endovascular prostheses, commonly known as stent-grafts or covered stents, used in the treatment of vascular diseases. These devices combine a metallic stent framework with a fabric or polymer graft covering and are primarily used for endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and other vascular pathologies. The standard establishes minimum requirements for materials, design attributes, manufacturing quality, and preclinical evaluation to ensure safety and performance of these life-saving implantable medical devices.
Endovascular prostheses are classified as Class III medical devices, representing the highest risk classification in medical device regulation. ISO 25539-1 provides the regulatory roadmap for manufacturers to demonstrate safety and effectiveness through rigorous design evaluation, bench testing, and preclinical in vivo studies before human clinical trials can begin. The standard is recognized by regulatory authorities worldwide including the US FDA and European notified bodies.
Endovascular prostheses are Class III medical devices. ISO 25539-1 provides the regulatory roadmap for demonstrating safety through design evaluation, bench testing, and preclinical studies before human clinical trials.
Device Classification and Design Attributes
The standard classifies endovascular prostheses by several design parameters. Configuration types include tube, bifurcated, uni-iliac, fenestrated, and branched designs. Deployment mechanisms include self-expanding devices using nitinol shape memory and balloon-expandable devices using stainless steel or cobalt-chromium alloys. Anchoring methods include suprarenal fixation with bare stent extending across renal arteries, infrarenal fixation, and active fixation using barbs or hooks. Design attributes that must be characterized include radiopacity, flexibility, kink resistance, fatigue resistance, sealing zone integrity, and delivery system performance.
| Parameter | Types / Specifications |
|---|---|
| Configuration | Tube, bifurcated, uni-iliac, fenestrated, branched |
| Stent material | Nitinol (self-expanding), 316L SS / Co-Cr (balloon-expandable) |
| Graft material | ePTFE, woven polyester (Dacron), polyurethane |
| Deployment mechanism | Self-expanding (thermal), balloon-expandable, mechanical |
| Fixation method | Suprarenal, infrarenal, active fixation (barbs/hooks) |
| Delivery system OD | 12 Fr to 24 Fr (4-8 mm) depending on device profile |
The modular design of bifurcated stent-grafts with a main body and contralateral limb represents one of the most important engineering innovations in vascular surgery, enabling minimally invasive AAA treatment through bilateral femoral access.
Design Evaluation and Bench Testing
ISO 25539-1 mandates a comprehensive design evaluation program covering bench tests, analytical modeling, and preclinical in vivo evaluation. Bench tests include dimensional verification, radial force measurement, leakage testing for porosity and seal zone assessment, migration resistance testing, fatigue testing in both pulsatile and dynamic modes, kink testing, and delivery system function testing. Accelerated pulsatile fatigue testing is required to simulate 10 years of in vivo service, approximately 400 million cycles, evaluating resistance to stent fracture, graft fabric wear, suture breakage, and component separation.
Preclinical Evaluation
| Category | Specific Tests | Duration |
|---|---|---|
| Bench tests | Radial force, sealing, migration, leakage, kink, fatigue | 1-6 months |
| Analytical modeling | FEA stress analysis, computational fluid dynamics | 1-3 months |
| In vivo evaluation | Animal implant, angiography, histopathology | 30-180 days |
| Delivery system testing | Trackability, pushability, deployment accuracy | 2-4 weeks |
| Sterilization validation | EO residual, bioburden, packaging integrity | 2-6 weeks |
Device fatigue testing must account for real-world anatomical variations. A stent-graft that performs well in a straight tube model may fail prematurely in a severely angulated aneurysm neck. The standard requires testing in worst-case configurations to ensure robust device design.
Clinical studies remain the ultimate validation step for endovascular prostheses. These studies must demonstrate safety and effectiveness in the intended patient population, with appropriate endpoints including aneurysm exclusion rate, secondary intervention rate, device patency, and freedom from aneurysm rupture. Long-term follow-up data extending to 5 and 10 years provides essential information about device durability and late complications. The standard references applicable clinical evaluation guidelines and emphasizes the importance of study design, statistical power, and appropriate endpoint selection for generating reliable clinical evidence.
Frequently Asked Questions
Q: What is the difference between a stent and a stent-graft?
A: A bare metal stent provides structural support to keep a vessel open. A stent-graft has a fabric covering that excludes aneurysms and seals off abnormal blood flow.
A: A bare metal stent provides structural support to keep a vessel open. A stent-graft has a fabric covering that excludes aneurysms and seals off abnormal blood flow.
Q: How long do endovascular prostheses last in the body?
A: Long-term data show 15 or more years of durability for many modern stent-grafts, with annual surveillance imaging recommended.
A: Long-term data show 15 or more years of durability for many modern stent-grafts, with annual surveillance imaging recommended.
Q: What is an endoleak?
A: Persistent blood flow into the aneurysm sac after stent-graft deployment, caused by incomplete sealing. Types include attachment site, branch flow, component separation, porosity, and endotension.
A: Persistent blood flow into the aneurysm sac after stent-graft deployment, caused by incomplete sealing. Types include attachment site, branch flow, component separation, porosity, and endotension.
Q: What are fenestrated stent-grafts?
A: Devices with customized openings aligning with branch vessels such as renal and mesenteric arteries, enabling treatment of aneurysms with short or unfavorable proximal necks.
A: Devices with customized openings aligning with branch vessels such as renal and mesenteric arteries, enabling treatment of aneurysms with short or unfavorable proximal necks.
